论文部分内容阅读
目的评价鹿瓜多肽注射液使用的合理性,提出风险管理建议,促进临床合理用药。方法调查分析骨科住院鹿瓜多肽注射液的使用情况,对其使用合理性进行分析与评价。结果调查用药940例,尚未见不良反应发生。鹿瓜多肽注射液在应用时存在超适应证、超剂量、溶媒选择不当、联合用药存在风险等问题。结论应制定干预措施,规范鹿瓜多肽注射液的使用,实现安全用药。
Objective To evaluate the rationality of using Lugua polypeptide injection, put forward risk management suggestions and promote the rational use of medicine. Methods Investigate the use of injection of Lugua polypeptide in the hospital of orthopedics and analyze its rationality. Results 940 cases investigated medication, no adverse reactions have occurred. Lugua peptide injection in the presence of superadministration, overdosage, improper solvent selection, combined with the risks of such issues. Conclusion Interventions should be formulated to standardize the use of Lugua polypeptide injection to achieve safe medication.